Russell Abberley

ABPI has appointed Russell Abberley as President-elect

The Association of the British Pharmaceutical Industry (ABPI) has appointed Russell Abberley, Vice President and General Manager of Amgen UK and Ireland, as President-elect.

Abberley has been serving as Acting ABPI President since September and will formally take up the Presidency on 13 May for a period of two years.

He holds over 25 years of life sciences industry experience across a range of geographies, and has served on the ABPI Board since 2020.

Prior to taking on his current role at Amgen, Abberley was Business Unit Director, General Medicine and Biosimilars at the company.

He has also held multiple roles at AstraZeneca, including Business Unit Director, Respiratory, Inflammation and Autoimmune, and served in positions at MSD and the Schering-Plough Research Institute.

Abberley said: “A proud advocate for our sector, I stand ready to work with the government on delivering its ambition to make the UK a life sciences powerhouse. By working together, we can improve the health of the nation and generate much needed economic growth.”

Also commenting on the appointment, Richard Torbett, ABPI Chief Executive said: “Russell has been great to work with as Acting President and is already a strong and valued member of our Board. I look forward to continuing our work together.”